CLINICAL SUPPLY MANAGEMENT ARTICLES
Clinical Trial Supply Chains Are Moving From Planning For Stability To Preparing For Uncertainty
Clinical trial supply can no longer rely on stable assumptions. Explore how scenario planning, smarter inventory strategies and connected data can build resilience.
CLINICAL SUPPLY MANAGEMENT RESOURCES
-
This article examines clinical trial complexity through the lens of study investigators, site staff, CRAs, sponsor study and supply managers, and how the RTSM/ IRT provides the ability to be as creative as needed.
-
This comprehensive guide provides practical insights and best practices for ensuring the timely, secure, and reliable delivery of clinical trial materials worldwide.
-
Flexible solutions, like demand-led supply and direct-to-patient distribution, are helping sponsors address the growing list of challenges presented by today’s increasingly complex studies.
-
Perhaps more than any other industry, pharma and biotech have undergone radical change over the past year, as a result of the COVID-19 pandemic. From supply chain security and capacity to clinical trial operations and site auditing, almost every aspect has been affected. Experts explore how these trends are shaping the industry and offer an outlook.
-
Reliable clinical supply requires proper vendor selection, cross-functional communication, and safety nets built to accommodate an ever-changing geopolitical and global pharmaceutical landscape. To avoid supply disruptions for clinical drugs, sponsors must give clinical supply its proper weight in initial protocol development and trial design.
-
Learn how the integral role of Direct-to-Patient Services plays a part in the execution of decentralized trials and how sponsors can maximize these benefits to improve drug development.
-
How can a randomization and trial supply management approach to track and trace help improve its efficiency and efficacy? Find out the answer in this white paper.